← Back to Search

Behavioral Intervention

Strategy Training for Hemispatial Neglect

N/A
Recruiting
Led By Emily Grattan, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥18 years old
Primary diagnosis of stroke
Must not have
Diagnosis of dementia indicated in medical record
Diagnosis of active major depressive disorder/bipolar/psychotic disorder indicated in medical record
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (up to 3 weeks)
Awards & highlights

Summary

"This trial aims to study a new intervention called metacognitive strategy training, which could help individuals who have difficulty paying attention to one side of their body or environment after a stroke. This training could potentially

Who is the study for?
This trial is for adults over 18 who've had a stroke and are now in rehab with unilateral spatial neglect, meaning they have trouble noticing one side of their body or environment. They must score below certain levels on specific tests that measure attention issues.
What is being tested?
The study is testing 'strategy training' to see if it can help improve self-awareness, reduce disability, and address neglect by teaching patients how to better pay attention to the neglected side of their space.
What are the potential side effects?
Since strategy training involves cognitive exercises rather than medication, typical drug-related side effects aren't expected. However, participants may experience fatigue or frustration during the learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with a stroke.
Select...
I am admitted to a rehab facility.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My medical records show a dementia diagnosis.
Select...
My medical records show I have major depression, bipolar, or a psychotic disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (up to 3 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (up to 3 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in online self-awareness
Secondary study objectives
Client Satisfaction with Strategy Training

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Strategy TrainingExperimental Treatment1 Intervention
The strategy training intervention teaches individuals to develop personalized goals, self-assess their performance of daily activities, and develop and evaluate strategies designed to overcome barriers and improve their performance of daily activities. Participants use a workbook to support their application of the strategy training.
Group II: Attention ControlActive Control1 Intervention
The attention control intervention controls for the non-specific effects of strategy training. The study team will administer the standardized and dose-matched protocol, using scripted open-ended questions to facilitate participants' reflections on their rehabilitation activities and experiences. Participants complete a daily journal, merely reviewing their rehabilitation activities.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Strategy Training
2013
N/A
~180

Find a Location

Who is running the clinical trial?

American Occupational Therapy FoundationOTHER
13 Previous Clinical Trials
339 Total Patients Enrolled
6 Trials studying Stroke
136 Patients Enrolled for Stroke
University of PittsburghLead Sponsor
1,762 Previous Clinical Trials
16,347,965 Total Patients Enrolled
28 Trials studying Stroke
2,863 Patients Enrolled for Stroke
Emily Grattan, PhDPrincipal InvestigatorUniversity of Pittsburgh
~25 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top